Sternberg working memory performance following treatment with pramipexole in patients with moderate-to-severe restless legs syndrome

KY Jung, SM Kim, JY Song, BU Lee, C Lee, SK Lee… - Sleep Medicine, 2015 - Elsevier
Objectives We recently reported that the P300 amplitude related to the Sternberg working
memory (WM) task was significantly lower in drug-naïve severe restless legs syndrome …

Working memory deficit in patients with restless legs syndrome: an event-related potential study

SM Kim, JW Choi, C Lee, BU Lee, YS Koo, KH Kim… - Sleep Medicine, 2014 - Elsevier
Objective The aim of this study was to investigate whether there is a working memory (WM)
deficit in restless legs syndrome (RLS) patients, by studying the Sternberg WM task of event …

The acute effect of a low dosage of pramipexole on severe idiopathic restless legs syndrome: an open-label trial

G Merlino, P Dolso, R Canesin, I Cancelli… - …, 2007 - karger.com
Background: Pramipexole is a D3 dopaminergic agonist that has shown a major effect on
both sensory and motor manifestations of restless legs syndrome (RLS) in long-term trials …

Acute placebo-controlled sleep laboratory studies and clinical follow-up with pramipexole in restless legs syndrome

M Saletu, P Anderer, G Saletu-Zyhlarz, C Hauer… - European archives of …, 2002 - Springer
In a single-blind, placebo-controlled crossover trial, the acute efficacy of the dopamine
agonist pramipexole was investigated in 11 restless legs syndrome (RLS) patients by sleep …

Electrophysiologic disturbances during daytime in patients with restless legs syndrome: further evidence of cognitive dysfunction?

KY Jung, YS Koo, BJ Kim, D Ko, GT Lee, KH Kim… - Sleep Medicine, 2011 - Elsevier
BACKGROUNDS: It has been reported that patients with restless legs syndrome (RLS) may
have cognitive deficit. The authors performed EEG and ERP analysis during daytime to …

Randomized trial of pramipexole for patients with restless legs syndrome (RLS) and RLS-related impairment of mood

P Montagna, M Hornyak, J Ulfberg, SB Hong, J Koester… - Sleep medicine, 2011 - Elsevier
OBJECTIVES: Patients with restless legs syndrome (RLS) have an elevated prevalence of
mood disorders compared with the general population. We investigated the change of RLS …

A dose-ranging study of pramipexole for the symptomatic treatment of restless legs syndrome: polysomnographic evaluation of periodic leg movements and sleep …

L Jama, K Hirvonen, M Partinen, A Alakuijala, C Hublin… - Sleep medicine, 2009 - Elsevier
Objective: To evaluate, both polysomnographically and by subjective scales, the efficacy
and safety profile of pramipexole for restless legs syndrome (RLS) via a 3-week, double …

Efficacy and safety of pramipexole in Japanese patients with primary restless legs syndrome: A polysomnographic randomized, double-blind, placebo-controlled study

Y Inoue, K Hirata, K Kuroda, M Fujita, T Shimizu… - Sleep medicine, 2010 - Elsevier
OBJECTIVE: To evaluate the efficacy of pramipexole on polysomnographic measures,
patient ratings and a clinical rating in Japanese patients with primary restless legs syndrome …

[HTML][HTML] Abnormal sleep delta rhythm and interregional phase synchrony in patients with restless legs syndrome and their reversal by dopamine agonist treatment

JW Choi, MH Jeong, SJ Her, BU Lee… - Journal of Clinical …, 2017 - synapse.koreamed.org
Background and Purpose The purpose of this study was to characterize abnormal cortical
activity during sleep in restless legs syndrome (RLS) patients and to determine the effects of …

Changes of cortical excitability after dopaminergic treatment in restless legs syndrome

A Scalise, I Pittaro-Cadore, F Janes, R Marinig… - Sleep Medicine, 2010 - Elsevier
OBJECTIVE: Dopaminergic pathways are most likely involved in the pathophysiology of
restless legs syndrome (RLS). In previous investigations, an alteration of cortical excitability …